Duke Cancer Institute Cary — Cary, North Carolina

Duke Cancer Institute Cary is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke Cancer Institute Cary has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Gastric Neuroendocrine Carcinoma, Intestinal Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Carcinoma.

Sponsors: ECOG-ACRIN Cancer Research Group, Duke University.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Institute Cary?

Duke Cancer Institute Cary has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Institute Cary conducted?

Duke Cancer Institute Cary has 5 clinical trials on record, with 4 currently active. Their work covers Gastric Neuroendocrine Carcinoma, Intestinal Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Carcinoma.

Is Duke Cancer Institute Cary accredited by Crixeo Health?

Duke Cancer Institute Cary has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Institute Cary?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.